Ftse Mib
38.779,67
0,68%
DAX
23.419,48
1,30%
S&P 500
5.738,52
-1,78%
NASDAQ
18.069,26
-2,61%
Bitcoin
87.060,69
-3,19%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Solid Biosciences Inc (SLDB) Solid Biosciences Inc (SLDB) Notizie

Solid Biosciences Inc

SLDB
5,35
-0,41 (-7,12%)
07 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/3/202523:01EDGAR2Form S-3 - Registration statement under Securities Act of..
06/3/202522:58EDGAR2Form S-3 - Registration statement under Securities Act of..
06/3/202522:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202522:16GLOBESolid Biosciences Reports Fourth Quarter and Full Year 2024..
05/3/202514:00GLOBESolid Biosciences to Participate at Upcoming Investor..
04/3/202522:07GLOBESolid Biosciences Reports Inducement Grants Under Nasdaq..
25/2/202522:05EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
22/2/202500:04EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
18/2/202522:52EDGAR2Form 8-K - Current report
18/2/202522:47EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/2/202522:35EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
18/2/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/2/202513:07EDGAR2Form 8-K - Current report
18/2/202513:00GLOBESolid Biosciences Announces Pricing of Underwritten Offering
18/2/202512:55EDGAR2Form 8-K - Current report
18/2/202512:45GLOBESolid Biosciences Reports Positive Initial Clinical Data..
14/2/202523:25EDGAR2Form 144 - Report of proposed sale of securities
14/2/202523:23EDGAR2Form 144 - Report of proposed sale of securities
14/2/202523:20EDGAR2Form 144 - Report of proposed sale of securities
11/2/202522:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/2/202522:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/2/202522:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/2/202522:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/2/202522:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202514:00GLOBESolid Biosciences Reports Inducement Grants Under Nasdaq..
30/1/202500:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/1/202514:30GLOBESolid Biosciences Receives FDA Fast Track Designation for..
15/1/202522:05GLOBESolid Biosciences Outlines Key Priorities for Advancing..
14/1/202500:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202522:05GLOBESolid Biosciences to Present at the 43rd Annual J.P. Morgan..
07/1/202523:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202522:15GLOBESolid Biosciences Announces FDA IND Clearance for..
06/1/202514:00GLOBESolid Biosciences Reports Inducement Grants Under Nasdaq..
23/12/202422:05GLOBESolid Biosciences Added to the Nasdaq Biotechnology Index
04/12/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202414:00GLOBESolid Biosciences Announces Collaboration with Mayo Clinic..
03/12/202414:00GLOBESolid Biosciences Reports Inducement Grants Under Nasdaq..
26/11/202414:00GLOBESolid Biosciences to Participate at Upcoming Investor..
19/11/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202418:02EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
14/11/202414:00GLOBESolid Biosciences to Present at the Jefferies London..
12/11/202422:58EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
06/11/202422:05GLOBESolid Biosciences Reports Third Quarter 2024 Financial..
06/11/202422:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202414:00GLOBESolid Biosciences Reports Inducement Grants Under Nasdaq..
Apertura: 5,695 Min: 5,48 Max: 5,77
Chiusura: 5,76

La tua Cronologia

NASDAQ
SLDB
Solid Biosciences
EU
UEF5
UBS Lux Fund Solutions M...
LSE
45SK
Hsbc Bk. 24
TG
AVH
Akoustis Technologies
NASDAQ
MIRM
Mirum Pharmaceuticals
NASDAQ
RKLB
Rocket Lab USA
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci